by dave | Jan 29, 2019 | News, Schizophrenia
We are currently recruiting for several schizophrenia trials, both inpatient and outpatient. These are paid clinical trials. Some will require inpatient stay in our 20 bed clinical research unit; while others will enroll on an outpatient basis, so you can come and go... by dave | Jan 28, 2019 | Depression, News
We are a clinical trials center located in Gaithersburg, Maryland. We work with patients nationwide, and provide transportation to eligible research participants within the Baltimore-Washington DC Metro Area.Depression is a difficult and painful condition; one that... by dave | Jan 28, 2019 | Depression, News
We are currently enrolling for paid clinical trials investigating ketamine and ketamine like compounds. Esketamine is an investigational, fast acting anti-depressant that is used to treat major depressive disorder. It works through a different pathway than currently... by dave | Dec 14, 2018 | Bipolar Disorder, News
Bipolar disorder (previously known as manic-depressive disorder) is a psychiatric condition that impacts approximately 2.6 million Americans. This condition is characterized by “mood swings” which shift from mania to depression. A person with bipolar... by dave | Dec 13, 2018 | Depression, News
Major depressive episode is a psychiatric condition where someone feels depressed, most of the day, nearly every day, for at least two weeks. When someone experiences this kind of deep depression, and it lasts longer than two weeks, or if they experience multiple...
